Cera™ ASD Occluder Post-Market Clinical Follow-Up Study

RecruitingOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

January 3, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Atrial Septal Defect
Trial Locations (6)

Unknown

NOT_YET_RECRUITING

G.V.M.Carint Hospital, Myszków

NOT_YET_RECRUITING

Centre for Invasive Cardiology, Electrotherapy and Angiology G.V.M.Carint-Oswiecim, Oświęcim

NOT_YET_RECRUITING

Subcarpathian Centre for Cardiovascular Intervention G.V.M.Carint -Sanok, Sanok

RECRUITING

Polish-American Heart Clinics, Heart and Vascular Center in Tychy, American Heart of Poland Group, Tychy

NOT_YET_RECRUITING

Polish-American Heart Clinics 1st Department of Invasive Cardiology and Heart Failure in Ustroń, AHoP Group, Ustroń

NOT_YET_RECRUITING

Dr. Tytus Chałubiński County Hospital, Zakopane

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY